NHS logo
NHS logo
The Health Innovation Network (HIN) has worked with partners across the two south London Integrated care systems (ICS’s) to expand the provision of Diabetes structured education services to include digital and remote options to help manage the condition remotely. At the start of the pandemic, a significant challenge was created when diabetes structured education courses, […]
The HIN’s ESCAPE-pain team received requests from sites that were eager to pilot ESCAPE-pain classes using a digital platform. The team adapted to meet this need and supported sites to trial virtual delivery if they could. The ESCAPE-pain programme is an intervention for people with chronic joint pain. Covid-19 forced over 290 venues to suspend […]
The Health Innovation Network (HIN), in partnership with the End of Life Clinical network for London, secured funding from the NHS England (NHSE) personalisation team to work with Marie Curie nurses to create CMC records for care home residents in three nursing homes in South East London over a five week period. Care home residents […]
The HIN partnered with training provider Hayat Consultancy to run a pilot online My Wellbeing training course for care home staff in south London to improve mental wellbeing. This was intended to support care home staff who were affected by the Covid-19 pandemic. The Covid-19 pandemic raised a new set of challenges for care home […]
The Rapid Uptake Products (RUP) programme has been designed to support stronger adoption and spread of proven innovations. It identifies and supports products with NICE approval that support the NHS Long Term Plan’s key clinical priorities, but have lower than expected uptake to date. Interested in adopting a RUP innovation? Please contact hin.nhsaac@nhs.net.
The MedTech Funding Mandate (MTFM) policy aims to support getting effective and innovative medical devices, diagnostics and digital products to patients faster. This mandate will pilot with four former Innovation and Technology Payment (ITP) products from 1st April 2021. The chosen products are NICE approved and were selected as they met the criterion of being […]
The Pathway Transformation Fund (PTF) supports NHS organisations to increase adoption of the 2020/21 Rapid Uptake Products (RUPs). The three eligible products include: NHS organisations will be able to submit PTF applications from 4 January 2021 until midday, 30 April 2021. Read the guidance notes here, here, here and then application forms here. Contact the Health Innovation […]
Coronary heart disease (CHD) is the world’s number one killer, accounting for 15% of UK deaths in 2019¹. HeartFlow FFRCT analysis provides clinicians with a more efficient pathway for diagnosing CHD that combines simulation models and medical imaging data. Previously, diagnosis of CHD was determined primarily by coronary angiography, an invasive and costly procedure. To […]
Pre-eclampsia (PE) affects approximately three per cent of all pregnancies and is a serious cause of maternal and foetal morbidity. There is no definitive test to help diagnose PE and the only “cure” is delivery of the baby. High suspicion for the disease and a low threshold for admission places a considerable unnecessary burden on […]
SecurAcath is a small orange triangular device to afix a PICC or Vascular catheter to the patient by the skin through two subcutaneous hooks. It is on the Innovation and Technology Payment (ITP) programme to promote new ways outside of adhesive options that dislodge or cause adhesive reactions Our aim is to reduce costs for […]
GammaCore is a simple-to-use, handheld medical device that enables patients to self-administer discrete doses of non-invasive vagus nerve stimulation (nVNS) therapy to the neck. Cluster headache is a series of extremely painful headaches that has been described by patients and physicians as one of the most painful conditions known to man, leading to the condition […]
Of 1000 women who appropriately take Tamoxifen as chemoprevention, 30 will be prevented from developing breast cancer over a 5-year period. The AAC is launching this project to promote awareness, among primary care clinicians, of prescribing Tamoxifen to reduce the chance of developing breast cancer for women with familial risk of breast cancer Only 53% […]
The 2020/21 ITP programme supports NHS England’s commitment to accelerate the adoption and spread of proven and affordable innovations. The programme removes some of the financial and procurement barriers to introducing innovative medical devices, diagnostics and digital product The HIN is continuing to support the following themes through the 2020/21 ITP programme: The Innovation Technology […]
FeNO (Fractional exhaled Nitric Oxide) testing alongside the recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of the asthma population, are wrongly diagnosed and given inappropriate medication. Our project will look to reduce the use of steroids and improve diagnosis, enabling correct adjustments or the […]
HIN project staff will be given the scope of the project from NHSE/AAC on launch to canvas our members for interest/inclusion into the project and to apply for pathway transformation funding (PTF) to support local work considered in scope. Please get in touch with the team for further information.
PINCER is the Pharmacist-led Information technology iNtervention for the reduction of Clinically important ERrors in medicines management. PINCER searches GP clinical systems using computerised prescribing safety indicators to identify patients that have been prescribed multiple medicines that may not always work together or require specific monitoring. The software works to flag these patients, so that […]
In 2019, 45.6% and 20.7% of London ‘years lived with disability’ (YLD) following CHD or stroke respectively were attributed to high LDL cholesterol¹. The Rapid Uptake Product for lipid management is a novel, NICE-approved clinical pathway, aiming to improve people’s lipid profiles. Lipid Management: High-Intensity Statins, Ezetimibe and PCSK9 inhibitors is one of the NHS […]
The HIN has been commissioned to support a drive to equip members and partners to offer the Covid Oximetry @home model.
Covid-19 led to a rapid shift from face-to-face to remote telephone and video consultations in mental health. So what has this meant for service users and staff? Covid-19 has meant significant changes in how mental health services in south London have been delivered, with a particular shift from face-to-face appointments to video and phone consultations. Our project […]
Guy’s and St Thomas’ YES programme gives 14-19 year-olds in south London the support they need to live with Type 1 diabetes. Participants meet other young people with Type 1 diabetes, building confidence and developing a peer support network. Learn how the Health Innovation Network (HIN) supported the programme to scale up from one London […]
In 2020, the HIN worked with the South East London Integrated Care System to explore how modern telephony systems can impact primary care service delivery. This culminated in the creation of a telephony commissioning guide which can be downloaded below. Modernising Primary Care Telephony from Health Innovation Network on Vimeo. In 2019 poor telephone systems […]
We are supporting three rheumatology departments across south east London (SEL) to trial a new service that supports patients with rheumatoid arthritis (RA) to remotely monitor their condition. The service aims to help people access the care they need, when they most need it, rather than rely on routine appointments. Starting in 2019, we brought […]
The HIN engaged with OPUS and commissioned them on a pro bono basis to adapt their existing comprehensive guidance to ensure care home staff were aware of how to safely administer medicines without using a dosette box during the pandemic. We shared the adapted guidance with our care homes with the permission of OPUS. The […]
With outpatient appointments reduced due to the pandemic, the South East London Diabetes Foot Network which covers seven London boroughs and a population of two million, had to continue high-quality, intensive diabetes foot care. The Diabetes team have supported the network to help the coordination of urgent diabetic foot care while maintaining high-quality pandemic response […]